Supplementary Material: Reaching the Target: Real-World Attainment and Prognostic Value of International Eczema Council Low Disease Activity States in a Cohort of Patients with Atopic Dermatitis Treated with JAK Inhibitors

Published: 2 November 2026| Version 1 | DOI: 10.17632/dz5t7zzf8k.1
Contributor:
Emilio Berna-Rico

Description

Supplementary material for the Letter to the Editor “Reaching the Target: Real-World Attainment and Prognostic Value of International Eczema Council Low Disease Activity States in a Cohort of Patients with Atopic Dermatitis Treated with JAK Inhibitors”. Mendeley Supplementary Tables 1–5 report the non-responder imputation denominators and target attainment, a landmark analysis of drug survival, and the univariate and multivariable analyses of factors associated with low disease activity attainment.

Files

Categories

Dermatology, Eczema, Atopy, Janus Kinase

Licence